Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 12.9367 | 99 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 12.8432 | 99 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 12.7803 | 99 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 12.9046 | 99 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 12.9339 | 99 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 13.1338 | 99 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 13.2537 | 99 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 12.9906 | 99 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 13.0461 | 99 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 13.0835 | 99 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 13.0933 | 99 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 13.0456 | 99 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 13.1372 | 99 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 13.0644 | 99 |